Etanercept therapy for immune-mediated cochleovestibular disorders: An open-label, pilot clinical trial.

被引：0
|
作者：
Choi, H
Poe, D
Wise, C
Rahman, M
Matteson, EL
机构：
[1] Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02114 USA
[2] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Div Rheumatol, Richmond, VA 23298 USA
[4] Mayo Clin, Rheumatol Unit, Rochester, MN USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S235 / S236
页数：2
相关论文
共 50 条
  • [1] Etanercept therapy for immune-mediated cochleovestibular disorders: A multi-center, open-label, pilot study
    Matteson, EL
    Choi, HK
    Poe, DS
    Wise, C
    Lowe, VJ
    Mcdonald, TJ
    Rahman, MU
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (03): : 337 - 342
  • [2] Etanercept therapy for immune-mediated cochleovestibular disorders: Preliminary results in a pilot study
    Rahman, MU
    Poe, DS
    Choi, HK
    [J]. OTOLOGY & NEUROTOLOGY, 2001, 22 (05) : 619 - 624
  • [3] Etanercept therapy for immune-mediated cochleovestibular disorders preliminary results in a pilot study.
    Rahman, MU
    Poe, DS
    Choi, HK
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S404 - S404
  • [4] Methotrexate management of immune-mediated cochleovestibular disorders
    Sismanis, A
    Wise, CM
    Johnson, GD
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1997, 116 (02) : 146 - 152
  • [5] Etanercept in Wegener's granulomatosis (WG): Results of an open-label trial.
    Stone, JH
    Hellmann, DB
    Uhlfelder, MI
    Bedocs, NM
    Crook, SL
    Holbrook, J
    Hoffman, GS
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S315 - S315
  • [6] Antibodies to glycosphingolipid antigens in patients with immune-mediated cochleovestibular disorders
    Lake, GM
    Sismanis, A
    Ariga, T
    Yamawaki, M
    Gao, Y
    Yu, RK
    [J]. AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (02): : 175 - 178
  • [7] Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease
    Choueiter, Nadine F.
    Olson, Aaron K.
    Shen, Danny D.
    Portman, Michael A.
    [J]. JOURNAL OF PEDIATRICS, 2010, 157 (06): : 960 - U148
  • [8] A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
    Lee, Robert A.
    Dommasch, Erica
    Treat, James
    Sciacca-Kirby, Joslyn
    Chachkin, Samuel
    Williams, Jennifer
    Shin, Daniel B.
    Leyden, James J.
    Vittorio, Carmela
    Gelfand, Joel M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (04) : 565 - 573
  • [9] The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study
    Li, Sizhao
    Li, Wenli
    Jiang, Wei
    He, Linrong
    Peng, Qinglin
    Wang, Guochun
    Lu, Xin
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] An open-label trial of Etanercept in the treatment of ankylosing spondylitis
    Gorman, JD
    Sack, KE
    Davic, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S91 - S91
12345